IVF Devices and Consumables Market
Description
The global IVF devices and consumables market size reached USD 3.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 9.3 Billion by 2034, exhibiting a growth rate (CAGR) of 11.63% during 2026-2034.
In vitro fertilization (IVF) is an assisted reproductive technology (ART) that helps with fertility, prevents genetic problems, and assists in the conception of a child. It comprises several medicines and surgical procedures for ovulation, egg retrieval, insemination and fertilization, and embryo culture and transfer. It also helps in achieving a successful pregnancy and healthy baby in women with blocked or damaged fallopian tubes. In addition, it aids in male infertility problems by using intra-cytoplasmic sperm injection (ICSI) for conceiving. At present, there is a rise in the utilization of IVF devices and consumables, such as instruments, accessories and disposable, and reagents and media, on account of the increasing rate of infertility across the globe.
IVF DEVICES AND CONSUMABLES MARKET TRENDS:
The rising awareness among the masses about the benefits of using IVF devices and consumables for a successful pregnancy represents one of the key factors propelling the market growth. Besides this, there is an increase in the number of delayed pregnancies worldwide. This, along with the burgeoning healthcare industry, is contributing to the growth of the market. Moreover, the rising number of gamete donations around the world to help intended parents have a child is offering lucrative growth opportunities to industry investors. In addition, governments of several countries are extensively investing in healthcare infrastructures, which is positively influencing the market. Apart from this, key market players are financing research and development (R&D) activities for improving embryo culture and cryopreservation and in vitro maturation. They are also focusing on several marketing strategies to increase their customer base. Additionally, the integration of artificial intelligence (AI) in IVF for the identification of an embryo is bolstering the growth of the market.
KEY MARKET SEGMENTATION:
IMARC Group provides an analysis of the key trends in each sub-segment of the global IVF devices and consumables market report, along with forecasts at the global, regional and country level from 2026-2034. Our report has categorized the market based on product, technology and end user.
Breakup by Product:
The report provides a comprehensive analysis of the competitive landscape in the global IVF devices and consumables market with detailed profiles of all major companies, including:
In vitro fertilization (IVF) is an assisted reproductive technology (ART) that helps with fertility, prevents genetic problems, and assists in the conception of a child. It comprises several medicines and surgical procedures for ovulation, egg retrieval, insemination and fertilization, and embryo culture and transfer. It also helps in achieving a successful pregnancy and healthy baby in women with blocked or damaged fallopian tubes. In addition, it aids in male infertility problems by using intra-cytoplasmic sperm injection (ICSI) for conceiving. At present, there is a rise in the utilization of IVF devices and consumables, such as instruments, accessories and disposable, and reagents and media, on account of the increasing rate of infertility across the globe.
IVF DEVICES AND CONSUMABLES MARKET TRENDS:
The rising awareness among the masses about the benefits of using IVF devices and consumables for a successful pregnancy represents one of the key factors propelling the market growth. Besides this, there is an increase in the number of delayed pregnancies worldwide. This, along with the burgeoning healthcare industry, is contributing to the growth of the market. Moreover, the rising number of gamete donations around the world to help intended parents have a child is offering lucrative growth opportunities to industry investors. In addition, governments of several countries are extensively investing in healthcare infrastructures, which is positively influencing the market. Apart from this, key market players are financing research and development (R&D) activities for improving embryo culture and cryopreservation and in vitro maturation. They are also focusing on several marketing strategies to increase their customer base. Additionally, the integration of artificial intelligence (AI) in IVF for the identification of an embryo is bolstering the growth of the market.
KEY MARKET SEGMENTATION:
IMARC Group provides an analysis of the key trends in each sub-segment of the global IVF devices and consumables market report, along with forecasts at the global, regional and country level from 2026-2034. Our report has categorized the market based on product, technology and end user.
Breakup by Product:
- Instruments
- Sperm Separation Systems
- Cryosystems
- Incubators
- Imaging Systems
- Ovum Aspiration Pumps
- Cabinets
- Micromanipulators
- Others
- Accessories and Disposables
- Reagents and Media
- Cryopreservation Media
- Semen Processing Media
- Ovum Processing Media
- Embryo Culture Media
- Fresh Embryo IVF
- Frozen Embryo IVF
- Donor Egg IVF
- Fertility Clinics
- Hospitals
- Surgical Centers
- Clinical Research Institutes
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
The report provides a comprehensive analysis of the competitive landscape in the global IVF devices and consumables market with detailed profiles of all major companies, including:
- Coopersurgical Inc.
- Genea BIOMEDX
- Hamilton Thorne
- InterMedics Healthcare LLP
- Kitazato Corporation
- LabIVF APAC Pte Ltd
- Memmert GmbH + Co.KG
- Nidacon International AB
- Rocket Medical
- Thermo Fisher Scientific Inc.
- Vitrolife
Table of Contents
141 Pages
- 1 Preface
- 2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
- 3 Executive Summary
- 4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
- 5 Global IVF Devices and Consumables Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
- 6 Market Breakup by Product
- 6.1 Instruments
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Sperm Separation Systems
- 6.1.2.2 Cryosystems
- 6.1.2.3 Incubators
- 6.1.2.4 Imaging Systems
- 6.1.2.5 Ovum Aspiration Pumps
- 6.1.2.6 Cabinets
- 6.1.2.7 Micromanipulators
- 6.1.2.8 Others
- 6.1.3 Market Forecast
- 6.2 Accessories and Disposables
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Reagents and Media
- 6.3.1 Market Trends
- 6.3.2 Key Segments
- 6.3.2.1 Cryopreservation Media
- 6.3.2.2 Semen Processing Media
- 6.3.2.3 Ovum Processing Media
- 6.3.2.4 Embryo Culture Media
- 6.3.3 Market Forecast
- 7 Market Breakup by Technology
- 7.1 Fresh Embryo IVF
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Frozen Embryo IVF
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Donor Egg IVF
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 8 Market Breakup by End User
- 8.1 Fertility Clinics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Hospitals
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Surgical Centers
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Clinical Research Institutes
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
- 10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
- 11 Value Chain Analysis
- 12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
- 13 Price Analysis
- 14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Coopersurgical Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Genea BIOMEDX
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Hamilton Thorne
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.4 InterMedics Healthcare LLP
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Kitazato Corporation
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 LabIVF APAC Pte Ltd
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Memmert GmbH + Co.KG
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Nidacon International AB
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.9 Rocket Medical
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 Thermo Fisher Scientific Inc.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Vitrolife
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
